Literature DB >> 1739421

Effect of etomoxiryl-CoA on different carnitine acyltransferases.

K Lilly1, C Chung, J Kerner, R VanRenterghem, L L Bieber.   

Abstract

The effects of etomoxiryl-CoA on purified carnitine acyltransferases and on carnitine acyl-transferases of rat heart mitochondria and rat liver microsomes were determined. At nanomolar concentrations, the data agreed with that of other investigators who have shown that etomoxiryl-CoA must be binding to a high affinity site with specific inhibition of mitochondrial carnitine palmitoyltransferase (CPTo). Micromolar amounts of etomoxiryl-CoA inhibited both short- and long-chain carnitine acyltransferases. The concentrations of etomoxiryl-CoA required for 50% inhibition of the different carnitine acetyltransferases and microsomal and peroxisomal carnitine octanoyltransferase were in the low micromolar range. Mixed-type and uncompetitive inhibition kinetics were obtained, depending on the source of purified enzyme. When purified rat heart CPT was incubated with etomoxiryl-CoA, it increased the K0.5 and decreased the Hill coefficient for acyl-CoA. Both proteins and phospholipids of mitochondria and microsomes formed covalent adducts of [3H]etomoxir, with the predominant labeling in phospholipids. None of the purified enzymes formed covalent adducts when incubated with [3H]etomoxiryl-CoA, in contrast to intact mitochondria or microsomes. The major 3H-labeled protein for rat heart mitochondria had a molecular weight of 81,000 +/- 4000, and the major proteins from microsomes had a molecular weight of 51,000-57,000. Malonyl-CoA prevented most of the tritum incorporation into the 81,000 Da protein of mitochondria, but it had little effect on incorporation of tritiated etomoxir into the 51,000-57,000 Da proteins of microsomes. When 50 microM etomoxiryl-CoA was added to microsomes and to mitochondria that had been incubated with radioactive etomoxiryl-CoA, much of the radioactive etomoxir disappeared from the major microsomal proteins, but virtually none was displaced from the mitochondrial protein. Thus, at least two different types of covalent etomoxir complexes were formed. This pulse-chase experiment showed that the mitochondrial protein-etomoxir complex was not turned over, consistent with other data showing that etomoxir inhibited carnitine palmitoyltransferase. In contrast, the major protein-etomoxir complex in microsomes was turned over during the pulse-chase experiment.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1739421     DOI: 10.1016/0006-2952(92)90298-w

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  10 in total

1.  Inhibition by etomoxir of rat liver carnitine octanoyltransferase is produced through the co-ordinate interaction with two histidine residues.

Authors:  M Morillas; J Clotet; B Rubí; D Serra; J Ariño; F G Hegardt; G Asins
Journal:  Biochem J       Date:  2000-10-15       Impact factor: 3.857

2.  The flux control coefficient of carnitine palmitoyltransferase I on palmitate beta-oxidation in rat hepatocyte cultures.

Authors:  T D Spurway; H A Sherratt; C I Pogson; L Agius
Journal:  Biochem J       Date:  1997-04-01       Impact factor: 3.857

3.  Measurement of Fatty Acid β-Oxidation in a Suspension of Freshly Isolated Mouse Hepatocytes.

Authors:  Schuyler D Vickers; Dominique C Saporito; Roberta Leonardi
Journal:  J Vis Exp       Date:  2021-09-09       Impact factor: 1.424

4.  Steroidogenesis in MA-10 mouse Leydig cells is altered via fatty acid import into the mitochondria.

Authors:  Malena B Rone; Andrew S Midzak; Daniel B Martinez-Arguelles; Jinjiang Fan; Xiaoying Ye; Josip Blonder; Vassilios Papadopoulos
Journal:  Biol Reprod       Date:  2014-09-10       Impact factor: 4.285

5.  Glucometabolic consequences of acute and prolonged inhibition of fatty acid oxidation.

Authors:  Anne-Marie Lundsgaard; Andreas M Fritzen; Trine S Nicolaisen; Christian S Carl; Kim A Sjøberg; Steffen H Raun; Anders B Klein; Eva Sanchez-Quant; Jakob Langer; Cathrine Ørskov; Christoffer Clemmensen; Matthias H Tschöp; Erik A Richter; Bente Kiens; Maximilian Kleinert
Journal:  J Lipid Res       Date:  2019-11-12       Impact factor: 5.922

6.  Over-expression and characterization of active recombinant rat liver carnitine palmitoyltransferase II using baculovirus.

Authors:  T M Johnson; W R Mann; C J Dragland; R C Anderson; G M Nemecek; P A Bell
Journal:  Biochem J       Date:  1995-07-15       Impact factor: 3.857

7.  Palmitate-induced skeletal muscle insulin resistance does not require NF-κB activation.

Authors:  Pascal P H Hommelberg; Jogchum Plat; Lauren M Sparks; Annemie M W J Schols; Anon L M van Essen; Marco C J M Kelders; Denis van Beurden; Ronald P Mensink; Ramon C J Langen
Journal:  Cell Mol Life Sci       Date:  2010-09-05       Impact factor: 9.261

Review 8.  Cardiac substrate uptake and metabolism in obesity and type-2 diabetes: role of sarcolemmal substrate transporters.

Authors:  Susan L M Coort; Arend Bonen; Ger J van der Vusse; Jan F C Glatz; Joost J F P Luiken
Journal:  Mol Cell Biochem       Date:  2007-05       Impact factor: 3.842

9.  CDK9 Inhibition Induces a Metabolic Switch that Renders Prostate Cancer Cells Dependent on Fatty Acid Oxidation.

Authors:  Harri M Itkonen; Ninu Poulose; Suzanne Walker; Ian G Mills
Journal:  Neoplasia       Date:  2019-05-28       Impact factor: 5.715

10.  Effect of Toxicants on Fatty Acid Metabolism in HepG2 Cells.

Authors:  David Grünig; Urs Duthaler; Stephan Krähenbühl
Journal:  Front Pharmacol       Date:  2018-04-23       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.